Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
CrowdStrike dominated analyst activity Thursday. Three firms raised their price targets in rapid succession. UBS moved from $525 to $790. Citigroup lifted to $780 from $525. Macquarie set a $660 target. The consensus target jumped to $684 from $571. All three kept buy or hold ratings.
The moves follow CrowdStrike's latest earnings beat. The cybersecurity giant carries a $190 billion market cap. Short interest sits at just 2.97% of free float. Bears have little grip here.
Fair Isaac drew an upgrade from the consensus view. Its average target price nudged to $1,528 from $1,532. FICO's short interest runs at 8.9% of free float — elevated for a $27 billion company.
Ciena saw its consensus target rise to $488 from $477. The networking firm has ballooned to an $88 billion market cap. Analysts grew more bullish after strong quarterly numbers.
Ulta Beauty took a hit. Citigroup's Steven Zaccone cut his target to $560 from $600. The rating stayed at Hold. Medtronic also faced a trim. UBS lowered its target to $85 from $90, maintaining a Hold stance.
Broadcom received a small cut too. UBS trimmed to $485 from $490. The Buy rating held firm despite the modest reduction.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
